| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 04/28/2005 | US20050090398 Aryl ketone derivatives containing tetrazole moieties such as 5-cyclopropyl-4-{2,4-dichloro-3-[(1H-tetrazol-1-yl)methyl]benzoyl}isoxazole; good effect as a selective herbicide for paddy rice |
| 04/28/2005 | US20050089781 Electroconductive substrate overcoated with photoconductive layer containing charge transfer compounds, charge generating compound |
| 04/28/2005 | US20050089713 Organic electroluminescent element |
| 04/28/2005 | CA2542807A1 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | CA2542653A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 04/28/2005 | CA2542370A1 Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
| 04/27/2005 | EP1526133A1 Epothilone derivatives |
| 04/27/2005 | EP1526132A2 Substituted oxazolidinone derivatives and their use as factor xa inhibitors |
| 04/27/2005 | EP1525200A1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 04/27/2005 | EP1525199A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 04/27/2005 | EP1525193A2 Acylaminothiazole derivatives, preparation and therapeutic use thereof |
| 04/27/2005 | EP1524979A2 New effector conjugates, process for their production and their pharmaceutical use |
| 04/27/2005 | EP1423110A4 Cbi analogues of cc-1065 and the duocarmycins |
| 04/27/2005 | EP1419150B1 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 04/27/2005 | EP1143974B1 Pharmaceutical compositions for alleviating discomfort |
| 04/27/2005 | EP0838453B1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 04/27/2005 | CN1610677A Halogenated nitrobutadienes for controlling animal pests |
| 04/27/2005 | CN1610675A Benzothiazole- and benzoxazole-4, 7-dione derivatives and their use as CDC25 phosphatase inhibitors |
| 04/27/2005 | CN1610674A Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 04/27/2005 | CN1610673A Method for producing pyrazole compound |
| 04/27/2005 | CN1610671A Quinoline compounds with 5-HT-antagonistic properties for therapy |
| 04/27/2005 | CN1610670A 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 04/27/2005 | CN1610666A Benzamidine derivative |
| 04/27/2005 | CN1610549A Epermycin derivative for treating difficult to cure tumor |
| 04/27/2005 | CN1610547A N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor |
| 04/27/2005 | CN1610546A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 04/27/2005 | CN1198833C Vinyl pyrrolidone cephlosporins with basic substitutent group |
| 04/27/2005 | CN1198822C Thiadiazolyl pyridazine derivatives with angiogenesis inhibiting |
| 04/27/2005 | CN1198820C N-substituted nitrogen heterocyclic compound |
| 04/27/2005 | CN1198806C Oxodiethylenediamine derivative and light stabilized composition |
| 04/27/2005 | CN1198803C Heterocyclic compounds having effect of activating nicoting acetylchloine alpha 4 beta 2 receptor |
| 04/26/2005 | US6885026 Organic element for electroluminescent devices |
| 04/26/2005 | US6884891 Methine dyes, manufacturing methods thereof, and silver halide photographic materials containing same dyes |
| 04/26/2005 | US6884821 Alkyloxypropanoic acid derivative containing sulfonamide or amide group are useful as insulin resistance agent |
| 04/26/2005 | US6884815 An amino compound containing imidazole and aromatic, or heteroaromatic rings is useful for treating inflammatory and immune system disorders |
| 04/26/2005 | US6884813 Microbiocides used to treat eye and skin infections |
| 04/26/2005 | US6884808 Acids and salts such as 4-(4-(2-(2-(5,6,7,8-Tetrahydro-5,5,8, 8-tetramethylquinoxalyl))pyrrolyl))benzoic acid, used retinoic acid receptor agonists for the prophylaxis of cancer, skin disorders, asthma, alopecia or autoimmune diseases |
| 04/26/2005 | US6884804 Inhibitors of Src and other protein kinases |
| 04/26/2005 | US6884802 Phenanthridines substituted in position 6 by a mono, bi- or tricyclic heteroaryl radical; cyclic nucleotidephosphoesterase (PDE4) inhibitor and useful for treating respiratory system disorders |
| 04/26/2005 | US6884801 Nitrogen compounds such as N-(4,5-dihydro-1H-imidazol-2-yl-methyl)-2-(methylsulfonyl)aniline, used for prophylaxis of incontinence |
| 04/26/2005 | US6884758 2,4-Diamino-1,3,5-triazines, their preparation, and their use as herbicides and plant growth regulators |
| 04/26/2005 | US6884265 A stable direct dyes, hair dyes, like oxidation color dyes, chemical resistance, photostability, weatherproofing, wash and wear; comprising imidazolinium, triazolium and pyridinium groups |
| 04/26/2005 | CA2213124C Benzoyl derivatives |
| 04/26/2005 | CA2053253C New aryl-and heteroarylethenylene derivatives and process for their preparation |
| 04/21/2005 | WO2005035551A2 Inhibitors of proteins that bind phosphorylated molecules |
| 04/21/2005 | WO2005035531A1 POLYMORPHIC FORMS OF ZIPRASIDONE HCl AND PROCESSES FOR THEIR PREPARATION |
| 04/21/2005 | WO2005035522A1 1-‘2-(4-hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists |
| 04/21/2005 | WO2005035510A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy |
| 04/21/2005 | WO2005035508A2 Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides |
| 04/21/2005 | WO2005035505A2 Compounds with phosphodiesterase inhibiting and calcium channel blocking activities |
| 04/21/2005 | WO2005034955A1 Substituted quinolines as protein tyrosine kinase enzyme inhibitors |
| 04/21/2005 | WO2005034941A1 Indoles and azaindoles as antiviral agents |
| 04/21/2005 | WO2005034870A2 Amide compounds and ion channel ligands and uses thereof |
| 04/21/2005 | WO2005034856A2 Targeted drug-formaldehyde conjugates and methods of making and using the same |
| 04/21/2005 | WO2005034848A2 Inhibitors of cathepsin s |
| 04/21/2005 | WO2005023807A3 4 - heterobicyclyamino - substituted quinazolines and analogues therof as capsaicin - antagonists |
| 04/21/2005 | WO2005004606A3 Pyridinylanilides |
| 04/21/2005 | WO2004094375A3 4 - (3,4 - disubstituted phenyl) - pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors |
| 04/21/2005 | WO2004031174A8 Imidazol-1-ylmethyl pyridazine derivatives |
| 04/21/2005 | WO2004026863A8 Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors |
| 04/21/2005 | US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 04/21/2005 | US20050085531 Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 04/21/2005 | US20050085514 Psychological disorders; schizophrenia; anxiolytic agents; antidepressants; bipolar diseases; circadian rhythm disorders; analgesics; Parkinson's disease; Huntington's disease |
| 04/21/2005 | US20050085509 KInase inhibitors; antiarthritic agents; autoimmune diseases; sepsis; cachexia; Alzheimer's disease; antihistamines; thrombosis; glomerulonephritis; inflammatory bowel disorders; crohn's disese; multiple sclerosis; antitumor agents; skin disorders |
| 04/21/2005 | US20050085497 Anticholesterol agents; reducing blood serum lipids; anticancer agents; antiarthritic agents; antiinflammatory agents; antitumor agents; immunosuppressants; obesity; hypotensive agents |
| 04/21/2005 | US20050085496 Microbiocidal n-phenyl-n-{4-(4-pyridyl)-2-pyrimidin-2-yl}-amine derivatives |
| 04/21/2005 | US20050085494 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
| 04/21/2005 | US20050085476 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 04/21/2005 | US20050085467 Androgen receptor antagonists |
| 04/21/2005 | US20050085466 such as 1-[4-(2-oxo-4-trifluoromethyl-1,2-dihydroquinolin-6-ylmethyl)benzenesulfonyl]-piperidine-3-carboxylic acid ethyl ester; for treatment of acne, alopecia, and oily skin; kits |
| 04/21/2005 | US20050085459 Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 |
| 04/21/2005 | US20050085457 Therapeutic quinolone compounds with 5-ht-antagonistic properties |
| 04/21/2005 | CA2542034A1 Thiadiazoline derivatives |
| 04/21/2005 | CA2541831A1 1-'2-(4-hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists |
| 04/21/2005 | CA2541582A1 Indoles and azaindoles as antiviral agents |
| 04/21/2005 | CA2535930A1 Inhibitors of cathepsin s |
| 04/21/2005 | CA2528100A1 Polymorphic forms of ziprasidone hcl and processes for their preparation |
| 04/20/2005 | EP1523533A1 Luminescent compositions |
| 04/20/2005 | EP1523493A1 Novel tubulysin analogues |
| 04/20/2005 | EP1443934B1 Benzotriazepines as gastrin and cholecystokinin receptor ligands |
| 04/20/2005 | EP1349847B1 Oxybenzamides derivatives as factor xa inhibitors |
| 04/20/2005 | EP1349843B1 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors |
| 04/20/2005 | EP1254133B1 Indol-3-yl derivatives and their use as integrin inhibitors |
| 04/20/2005 | EP1252158B1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 04/20/2005 | EP1140904B1 Farnesyl protein transferase inhibitors |
| 04/20/2005 | EP1029851B1 Piperazine compounds and medicinal use thereof |
| 04/20/2005 | EP0984947B1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| 04/20/2005 | EP0766669B1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 04/20/2005 | CN1608065A Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase and pharmaceutical compositions containing the compounds |
| 04/20/2005 | CN1608061A Therapeutic isoquinoline compounds |
| 04/20/2005 | CN1608056A Carboxylic acid derivative compounds and agents comprising the compounds as active ingredient |
| 04/20/2005 | CN1608054A Therapeutic quinolone compounds with 5-HT-antagonistic properties |
| 04/20/2005 | CN1607202A Antibiotic compound, pharmaceutical composition comprising the same and application thereof |
| 04/20/2005 | CN1197861C Method for preparing solid optical pure neutral S- (-) - and (R) - (+) -Omeprazole |
| 04/19/2005 | US6881844 Indole-3-carboxamides as glucokinase activators |
| 04/19/2005 | US6881840 Useful in imaging elements including silver halide photographic materials and inkjet materials; do not cause undesirable fluorescence |
| 04/19/2005 | US6881753 Potassium channel inhibitors and method |
| 04/19/2005 | US6881741 Such as 3-(4-Chloro-2,5-dimethyl-benzenesulfonylamino)-5-(4-chloro-phenyl)-thiophene-2-carboxylic acid; for treatment of hepatitis |
| 04/19/2005 | US6881740 Pharmaceutical agents |
| 04/19/2005 | US6881736 Inhibit the vitronectin receptor and are useful for the treatment of inflammation, cancer and cardiovascular disorders, such as atherosclerosis and restenosis, and diseases wherein bone resorption is a factor, such as |